Would you like to receive important updates about Endo International PLC like earnings dates and more?
The Year To Date (YTD) return is -12.22%.
The 52 Week Low stock price is 5.77 set on Fri, Oct 27, 2017 which is 85 days ago.
The current price per share is 23.22% above the 52 week low.
The 52 Week High stock price is $14.45 set on Tue, Feb 28, 2017 which is 326 days ago.
The current price per share is -50.80% below the 52 week high.
The All Time High stock price is $96.58 set on Thu, Apr 16, 2015 which is 1,010 days ago.
The current price per share is -92.64% below the all time high.
The Endo 5 year stock chart shows the historical prices over the previous 60 months.
The Endo 1 year stock chart shows the historical prices over the previous 12 months.
The 50 Day Moving Average is at $10.15 which is 29.95% above the stock price of $7.11.
The 200 Day Moving Average is at 12.21 which is 41.77% above the stock price of $7.11.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
Endo International PLC is a Health Care stock that trades on the NASDAQ and has a market capitalization of $1.64 Billion.
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
The EPS is -$19.28 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
The Earnings Release Date was Thu, Nov 9, 2017.
Since this earnings release 72 days ago, the stock price is up by +16.75%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The next Earnings Release Date is on Tue, Feb 27, 2018, which is in 38 days.
ENDP currently does not pay a dividend.
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.